Tuesday March 31, 2020 02:47

Heathcare Press Release : 20 Nov 2019

Herbalife Nutrition Launches First Body Transformation Challenge Heathcare—20 Nov 19

A 12-Week Contest Exclusively Available to Professional Coaches and Herbalife Nutrition Members to Make a Healthy Change and Win Major Prizes Herbalife Nutrition (NYSE:HLF), a premier global nutrition company, recently launched its first "Body

Merck Announces Orphan Drug Designation for Investigational Therapy Tepotinib in Patients with NSCLC Harboring MET Gene Alterations Heathcare—20 Nov 19

DARMSTADT, Germany--20 Nov--PRNewswire/InfoQuest

Merck, a leading science and technology company, today announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has granted orphan drug designation (ODD) for its investigational therapy tepotinib* for patients with non-small cell lung cancer (NSCLC) harboring MET gene alterations.

"Advanced NSCLC harboring MET gene alterations is associated with aggressive tumor behavior and poor clinical prognosis," said Luciano Rossetti, Global Head of Research & Development for the Biopharma business of Merck. "This orphan drug designation helps to advance this program within Japan and, coupled with the SAKIGAKE 'fast-track' designation received last year, provides important mechanisms, such as priority review, to quickly deliver this medi

Strengthening the capacity of senior hospital management, boosting the occupational safety of Heathcare—20 Nov 19

The Healthcare Accreditation Institute of Thailand (Public Organization), GIZ Thailand and B. Braun (Thailand) Ltd. recently organized "Capacity Building for Senior Hospital Management for Healthcare Personnel Safety", a training session that

A leading global medicines company executes a strategic investment in SiO2 Medical Products gaining Heathcare—20 Nov 19

- Investment confirms interest to use SiO2's technology that may provide advantages including enhanced quality and performance - SiO2's breakthrough technology is anticipated to help provide regulatory benefits, enhanced primary packaging and potential

Excelra Announces a Drug Repurposing Collaboration With Maruho On Dermatological Heathcare—20 Nov 19

Excelra, a leading global Data and Analytics Company today announced a Drug Repurposing collaboration with Osaka-based Maruho – a pharmaceutical company specialising in Dermatology. Under the agreement, the Drug Repurposing Data Scientists and